A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound)

NCT05753865 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

454

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Breast Cancer

Interventions

DRUG: SYHX2011
DRUG: Paclitaxel for injection (albumin-bound)

Sponsor

CSPC Ouyi Pharmaceutical Co., Ltd.